HLA-A2 CAR/IL-2-CISC engineered Treg display robust in vitro and in vivo antigen-specific regulatory function. - Tripathi SK; Grimm A; Dahl NP; Honaker Y; Knebusch P; Chen Y; Cook PJ; Rawlings DJ (Molecular therapy. Methods & clinical development, 2025)